Pivalate

Pivalate

SCHEMBL587697

CC(C)(C)C(=O)[O-].CC(C)(C)C(=O)[O-].[Ca+2]

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHMGCRMMP1MMP13MMP7MMP8PTGS1PTGS2ileSpolrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Pivalate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.43
CA4 P22748 4/20 0.38
ALDH1A1 P00352 1/20 0.35
TSHR P16473 1/20 0.35
FAHD1 Q6P587 1/20 0.33
FFAR3 O14843 1/20 0.30
HDAC3 O15379 1/20 0.30
HDAC1 Q13547 1/20 0.30
HDAC2 Q92769 1/20 0.30
HDAC8 Q9BY41 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pivalate SCHEMBL3093699 0.92 CA1 (0.43) CA1CA4ALDH1A1TSHRFAHD1
Pivalate SCHEMBL18451999 0.92
Pivalate SCHEMBL1685640 0.92 CA1 (0.43) CA1CA4ALDH1A1TSHRFAHD1
Pivalate SCHEMBL2349136 0.92
Pivalate SCHEMBL1043179 0.92
Pivalate SCHEMBL25243131 0.92 CA1 (0.43) CA1CA4ALDH1A1TSHRFAHD1
Pivalate SCHEMBL2204587 0.92 CA1 (0.43) CA1CA4ALDH1A1TSHRFAHD1
Pivalate SCHEMBL6511225 0.92 CA1 (0.43) CA1CA4ALDH1A1TSHRFAHD1
Pivalate SCHEMBL1314523 0.92 CA1 (0.43) CA1CA4ALDH1A1TSHRFAHD1
Pivalate SCHEMBL300631 0.92 CA1 (0.43) CA1CA4ALDH1A1TSHRFAHD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260069911-A1 ENVIRONMENTALLY-CLEAN FIRE INHIBITING BIOCHEMICAL COMPOSITIONS, SOLUTIONS AND POWDERS, AND METHODS OF AND APPARATUS FOR PRODUCING FIRE PROTECTED WOOD PRODUCTS MIGHTY FIRE BREAKER LLC (US) 2026-03-12 US claimed
US-20260069910-A1 ENVIRONMENTALLY-CLEAN WATER-BASED FIRE INHIBITING BIOCHEMICAL SOLUTIONS AND METHODS OF AND APPARATUS FOR APPLYING THE SAME TO PROTECT PROPERTY AGAINST WILDFIRE MIGHTY FIRE BREAKER LLC (US) 2026-03-12 US claimed
US-20260048289-A1 ENVIRONMENTALLY-SAFE WATER-BASED FIRE RETARDANT BIOCHEMICAL COMPOSITIONS FORMULATED USING ALKALI METAL SALTS, FREE FROM PHOSPHATES, NITRATES, AND AMMONIUM-SALTS, FOR NON-CORROSIVE AERIAL AND GROUND DELIVERY ONTO PROPERTY REQUIRING LONG-TERM PROTECTION AGAINST WILDFIRE MIGHTY FIRE BREAKER LLC (US) 2026-02-19 US claimed
US-20260014403-A1 ENVIRONMENTALLY-CLEAN WATER-BASED FIRE INHIBITING BIOCHEMICAL COMPOSITIONS, SOLUTIONS, POWDERS AND METHODS OF AND APPARATUS FOR PRODUCING FIRE PROTECTED WOOD AND ENGINEERED WOOD PRODUCTS MIGHTY FIRE BREAKER LLC (US) 2026-01-15 US claimed
WO-2025245031-A1 ENVIRONMENTALLY-CLEAN WATER-BASED FIRE-INHIBITING BIOCHEMICAL SOLUTIONS, METHODS, AND APPARATUS FOR APPLYING TO PROTECT PROPERTY AGAINST WILDFIRE MIGHTY FIRE BREAKER LLC (US) 2025-11-27 WO claimed
US-20250121233-A1 ENVIRONMENTALLY-CLEAN WATER-BASED FIRE INHIBITING BIOCHEMICAL SOLUTIONS FORMULATED USING ALKALI METAL SALTS OF PIVALIC ACID FOR PROTECTING PROPERTY AGAINST WILDFIRE MIGHTY FIRE BREAKER LLC (US) 2025-04-17 US claimed
US-20240366982-A1 ENVIRONMENTALLY-CLEAN WATER-BASED FIRE INHIBITING BIOCHEMICAL COMPOSITIONS AND METHODS OF AND APPARATUS FOR APPLYING THE SAME TO PROTECT PROPERTY AGAINST WILDFIRE MIGHTY FIRE BREAKER LLC (US) 2024-11-07 US claimed
US-11306109-B2 Method for preparing silicon-containing heterocycles HENKEL AG & CO. KGAA (DE) 2022-04-19 US claimed
EP-1915349-B2 PROCESS FOR PREPARING PURE AMORPHOUS ROSUVASTATIN CALCIUM LEK PHARMACEUTICALS (SI) 2018-09-12 EP claimed
US-20180161365-A1 Phosphate-Binding Magnesium Salts And Uses Thereof CURRAX PHARMACEUTICALS LLC 2018-06-14 US claimed
US-20090269399-A1 PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF CYPRESS PHARMACEUTICAL, INC. (US) 2009-10-29 US claimed
US-20090111839-A1 Process for Preparing Amorphous Rosuvastatin Calcium of Impurities LEK PHARMACEUTICALS D.D. (SI) 2009-04-30 US claimed
JP-2008533128-A 2008-08-21 JP claimed
US-20080188504-A1 Process for Preparing Pure Amorphous Rosuvastatin Calcuim LEK D.D (SI) 2008-08-07 US claimed
EP-1915349-A2 PROCESS FOR PREPARING PURE AMORPHOUS ROSUVASTATIN CALCIUM LEK Pharmaceuticals D.D. (SI) 2008-04-30 EP claimed
EP-1912952-A1 PROCESS FOR PREPARING AMORPHOUS ROSUVASTATIN CALCIUM FREE OF IMPURITIES LEK Pharmaceuticals D.D. (SI) 2008-04-23 EP claimed
EP-1861364-A1 PREPARATION OF AN ATORVASTATIN INTERMEDIATE USING A PAAL-KNORR CONDENSATION Pfizer Science and Technology Ireland Limited (IE) 2007-12-05 EP claimed
WO-2006136408-A2 PROCESS FOR PREPARING PURE AMORPHOUS ROSUVASTATIN CALCIUM LEK PHARMACEUTICALS D.D. (SI) 2006-12-28 WO claimed
WO-2006136407-A1 PROCESS FOR PREPARING AMORPHOUS ROSUVASTATIN CALCIUM FREE OF IMPURITIES LEK PHARMACEUTICALS D.D. (SI) 2006-12-28 WO claimed
WO-2006097909-A1 PREPARATION OF AN ATORVASTATIN INTERMEDIATE USING A PAAL-KNORR CONDENSATION PFIZER SCIENCE AND TECHNOLOGY IRELAND LIMITED (IE) 2006-09-21 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260069910-A1 ENVIRONMENTALLY-CLEAN WATER-BASED FIRE INHIBITING BIOCHEMICAL SOLUTIONS AND METHODS OF AND APPARATUS FOR APPLYING THE SAME TO PROTECT PROPERTY AGAINST WILDFIRE CA2, CA1, CA7 CA1 2/4885CA4 10/4885ALDH1A1 3293/4885
US-20090111839-A1 Process for Preparing Amorphous Rosuvastatin Calcium of Impurities HMGCR, PCSK9, CACNA2D1 CA1 1207/4885CA4 356/4885ALDH1A1 4207/4885
US-20260014403-A1 ENVIRONMENTALLY-CLEAN WATER-BASED FIRE INHIBITING BIOCHEMICAL COMPOSITIONS, SOLUTIONS, POWDERS AND METHODS OF AND APPARATUS FOR PRODUCING FIRE PROTECTED WOOD AND ENGINEERED WOOD PRODUCTS ME1, ATP6V1A, ATP5MF CA1 5/4885CA4 47/4885ALDH1A1 308/4885
US-20260048289-A1 ENVIRONMENTALLY-SAFE WATER-BASED FIRE RETARDANT BIOCHEMICAL COMPOSITIONS FORMULATED USING ALKALI METAL SALTS, FREE FROM PHOSPHATES, NITRATES, AND AMMONIUM-SALTS, FOR NON-CORROSIVE AERIAL AND GROUND DELIVERY ONTO PROPERTY REQUIRING LONG-TERM PROTECTION AGAINST WILDFIRE CA3, CA2, FIBP CA1 6/4885CA4 20/4885ALDH1A1 2676/4885
US-20080188504-A1 Process for Preparing Pure Amorphous Rosuvastatin Calcuim PCSK9, HMGCR, CARM1 CA1 208/4885CA4 404/4885ALDH1A1 3683/4885
US-11306109-B2 Method for preparing silicon-containing heterocycles C1S, C1R, C5 CA1 196/4885CA4 1504/4885ALDH1A1 2693/4885
US-20260069911-A1 ENVIRONMENTALLY-CLEAN FIRE INHIBITING BIOCHEMICAL COMPOSITIONS, SOLUTIONS AND POWDERS, AND METHODS OF AND APPARATUS FOR PRODUCING FIRE PROTECTED WOOD PRODUCTS FGB, ACTB, FOSB CA1 20/4885CA4 86/4885ALDH1A1 1371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.